BR9407397A - Hydrogel microencapsulated vaccines - Google Patents

Hydrogel microencapsulated vaccines

Info

Publication number
BR9407397A
BR9407397A BR9407397A BR9407397A BR9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A
Authority
BR
Brazil
Prior art keywords
hydrogel
microencapsulated
vaccines
microencapsulated vaccines
hydrogel microencapsulated
Prior art date
Application number
BR9407397A
Other languages
Portuguese (pt)
Inventor
Alexander K Andrianov
Sharon A Jenkins
Lendon G Payne
Bryan E Roberts
Original Assignee
Virus Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/090,841 external-priority patent/US5562909A/en
Application filed by Virus Res Inst filed Critical Virus Res Inst
Publication of BR9407397A publication Critical patent/BR9407397A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/025—Polyphosphazenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR9407397A 1993-07-12 1994-07-11 Hydrogel microencapsulated vaccines BR9407397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/090,841 US5562909A (en) 1993-07-12 1993-07-12 Phosphazene polyelectrolytes as immunoadjuvants
US08/147,781 US5529777A (en) 1993-07-12 1993-11-04 Hydrogel microencapsulated vaccines
PCT/US1994/007749 WO1995002416A1 (en) 1993-07-12 1994-07-11 Hydrogel microencapsulated vaccines

Publications (1)

Publication Number Publication Date
BR9407397A true BR9407397A (en) 1996-11-05

Family

ID=26782696

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407397A BR9407397A (en) 1993-07-12 1994-07-11 Hydrogel microencapsulated vaccines

Country Status (8)

Country Link
EP (1) EP0792161A4 (en)
JP (1) JPH09500132A (en)
CN (1) CN1128953A (en)
AU (1) AU690567B2 (en)
BR (1) BR9407397A (en)
CA (1) CA2167081A1 (en)
NZ (1) NZ269411A (en)
WO (1) WO1995002416A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM572294A0 (en) * 1994-05-18 1994-06-09 Vaccine Technologies Pty. Ltd. Delivery vehicle for bioactive molecule
US5674495A (en) * 1995-02-27 1997-10-07 Purdue Research Foundation Alginate-based vaccine compositions
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
US5807757A (en) * 1996-07-02 1998-09-15 Virus Research Institute, Inc. Preparation of ionically cross-linked polyphosphazene microspheresy by coacervation
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
WO1998048626A1 (en) * 1997-04-30 1998-11-05 Emory University Methods and compositions for administering dna to mucosal surfaces
AU751182B2 (en) * 1997-12-02 2002-08-08 Archimedes Development Limited Compositions for nasal administration
US7087236B1 (en) 1998-09-01 2006-08-08 Merrion Research I Limited Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
ES2243497T3 (en) 2000-05-12 2005-12-01 PHARMACIA & UPJOHN COMPANY LLC VACCINE COMPOSITION, SAME PREPARATION PROCEDURE AND VERTEBRATE VACCINATION PROCEDURE.
US20040131631A1 (en) * 2002-11-22 2004-07-08 Alexander Andrianov Polyphosphazene immunostimulants
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
WO2004066704A2 (en) 2003-01-17 2004-08-12 Cornell Research Foundation, Inc. Injectable hydrogel microspheres from aqueous two-phase system
CN101090710B (en) * 2004-10-25 2012-03-14 宝利策尼克斯有限公司 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
KR100784485B1 (en) 2006-01-18 2007-12-11 한국과학기술연구원 Biodegradable and thermosensitive polyorganophosphazene hydrogel, preparation method thereof and use thereof
EP1985284A1 (en) * 2007-04-25 2008-10-29 OctoPlus Sciences B.V. Vaccine formulation
WO2008100142A2 (en) * 2007-02-12 2008-08-21 Octoplus Sciences B.V. Vaccine formulation
EP2196196A1 (en) * 2008-12-10 2010-06-16 Medipol S.A. Compound, medicament, vaccine composition and nanocapsules
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
GB201212010D0 (en) * 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
MX2016007356A (en) 2013-12-06 2016-10-03 Advanced Bionutrition Corp Composition for oral delivery of bioactive agents.
US20180311175A1 (en) * 2015-10-28 2018-11-01 University Of Maryland, College Park Multifunctional biodegradable carriers for drug delivery
CN105214100A (en) * 2015-11-16 2016-01-06 中国医学科学院生物医学工程研究所 A kind of pH response microcapsule-type protein vaccine carrier and preparation method
CN112618709B (en) * 2019-09-24 2023-11-03 华南理工大学 Pig oral vaccination slow-release adjuvant and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880622A (en) * 1986-05-20 1989-11-14 Research Corporation Technologies, Inc. Water-soluble phosphazene polymers having pharmacological applications
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules

Also Published As

Publication number Publication date
NZ269411A (en) 2001-03-30
CN1128953A (en) 1996-08-14
AU7328694A (en) 1995-02-13
JPH09500132A (en) 1997-01-07
AU690567B2 (en) 1998-04-30
EP0792161A4 (en) 1998-04-29
EP0792161A1 (en) 1997-09-03
CA2167081A1 (en) 1995-01-26
WO1995002416A1 (en) 1995-01-26

Similar Documents

Publication Publication Date Title
BR9407397A (en) Hydrogel microencapsulated vaccines
DE69411221T2 (en) Tri-carbamate functional crosslinker
DE69533227D1 (en) REHYDRATED HYDROGEL
NO961757L (en) Vacuumlöfte device
BR9404448A (en) Together artuculate sphere
DE69431099T2 (en) Pipette-washing device
NO933753D0 (en) ROER-repair DEVICE
DK18793D0 (en) THERMOSTAT
IT1261545B (en) SINGULARIZER DEVICE
FI92525B (en) Ventilation-heating unit
DE69422018D1 (en) INTERFACE DEVICE
DE69419620D1 (en) FLUORATION PROCEDURE
DE69427178T2 (en) Modulators
FI930227A0 (en) Suspension device
FI941763A (en) Skin
DE9303814U1 (en) Application device
DE9314954U1 (en) Serving
KR950012854U (en) Thermostat
KR950010962U (en) Tee-up device
DE69409920T2 (en) Attached device
KR940026468U (en) Human Resources
KR950016466U (en) Handout
KR940020160U (en) Warming
SE9303844D0 (en) Suspension device
DE59402971D1 (en) interface

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
TC Change of name
ND Extension of time allowed
CKFC Appeal: appeal against refusal